Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

walfofwallstreet Sep. 4 at 10:57 AM

$IMRN remind me of $MDCX yesterday news 🗞️ with $PFE

0 · Reply

walfofwallstreet Sep. 4 at 10:53 AM

$MDCX 7 am rally 🎢👀👀👀🐺 Yesterday ran 30% at 7 am rally 🎢 $MDCX You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅huge👇👇💎 $IMRN 👀

0 · Reply

truthseeeker Sep. 4 at 10:40 AM

$PFE anyone who has read stocktwits message boards for year KNOWS that EXTREMISTS dominate the posts and the main thing to realize is that both sides of the EXTREMISTS essentially always describe and predict the least likely outcomes for share price and thus prove to be wrong. We see the same thing on this PFE board. PFE is not going to 33 neither is it going to 20.

0 · Reply

walfofwallstreet Sep. 4 at 9:38 AM

$MDCX huge today 💎👀👀👀🐺 Yesterday ran 30% at 7 am rally 🎢 $MDCX You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅huge👇👇💎

1 · Reply

DidYouReadThis Sep. 4 at 1:54 AM

$PFE

0 · Reply

LoneBroker Sep. 4 at 1:17 AM

$PFE $ETHE $IBIT

0 · Reply

Outcomes Sep. 4 at 12:39 AM

$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. Data, Outcomes. PSS KNOWS. https://x.com/nichulscher/status/2095647325553082505?s=46

0 · Reply

walfofwallstreet Sep. 4 at 12:08 AM

$MDCX Great close 💎 👌 Tomorrow 🫵can be huge 💎👀👀🐺 You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅huge👇👇💎

1 · Reply

Samishere Sep. 3 at 10:11 PM

$PFE

0 · Reply

CapitalMonk Sep. 3 at 9:29 PM

$PFE Price: $28.81 (-0.72%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.81% RSI: 71.2 | Momentum: Moderate Volume: -29.1% vs avg Volatility: 1.46% Support: $26.05 | Resistance: $29.21 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer

PCVX TEVA

Sep 2, 2026, 9:00 AM EDT - 1 day ago

Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

XRAY

Aug 31, 2026, 1:20 PM EDT - 3 days ago

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

LLY NVO TAK

Aug 31, 2026, 12:09 PM EDT - 3 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK

Aug 27, 2026, 5:48 PM EDT - 7 days ago

US FDA approves updated COVID vaccines for 2026-27 season

MRNA NVAX SNY BNTX

2026-08-27T20:35:15.000Z - 7 days ago

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

BNTX

Aug 27, 2026, 4:30 PM EDT - 7 days ago

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

BNTX

Aug 26, 2026, 12:48 PM EDT - 8 days ago

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

AMGN LLY

2026-08-24T12:18:00.000Z - 10 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-19T14:35:12.000Z - 15 days ago

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

2026-08-16T13:55:21.000Z - 18 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 20 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 20 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 20 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 20 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

2026-08-14T13:47:35.000Z - 20 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Aug 14, 2026, 1:00 AM EDT - 21 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 4 weeks ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 4 weeks ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 4 weeks ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 4 weeks ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 5 weeks ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 5 weeks ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 6 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 6 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 6 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 7 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 7 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 1 month ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 3 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 3 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 3 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 3 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

walfofwallstreet Sep. 4 at 10:57 AM

$IMRN remind me of $MDCX yesterday news 🗞️ with $PFE

0 · Reply

walfofwallstreet Sep. 4 at 10:53 AM

0 · Reply

truthseeeker Sep. 4 at 10:40 AM

0 · Reply

walfofwallstreet Sep. 4 at 9:38 AM

$MDCX huge today 💎👀👀👀🐺 Yesterday ran 30% at 7 am rally 🎢 $MDCX You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅huge👇👇💎

1 · Reply

DidYouReadThis Sep. 4 at 1:54 AM

$PFE

0 · Reply

LoneBroker Sep. 4 at 1:17 AM

$PFE $ETHE $IBIT

0 · Reply

Outcomes Sep. 4 at 12:39 AM

$IBRX $MRNA $MRK $PFE $JNJ mRNA BAD. Data, Outcomes. PSS KNOWS. https://x.com/nichulscher/status/2095647325553082505?s=46

0 · Reply

walfofwallstreet Sep. 4 at 12:08 AM

$MDCX Great close 💎 👌 Tomorrow 🫵can be huge 💎👀👀🐺 You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅huge👇👇💎

1 · Reply

Samishere Sep. 3 at 10:11 PM

$PFE

0 · Reply

CapitalMonk Sep. 3 at 9:29 PM

0 · Reply

walfofwallstreet Sep. 3 at 9:27 PM

$MDCX can be huge 💎👀👀🐺 You can’t go wrong with $1 billion deal with Pfizer $PFE New cancer drug The deal finalised ✅

0 · Reply

walfofwallstreet Sep. 3 at 8:57 PM

$MDCX finalized $1 billion deal with Pfizer $PFE 🫵 $MDCX Medicus get started on its new cancer drug 💎 This is huge 💎 The deal worth $1 billion 🤯

0 · Reply

Agent8 Sep. 3 at 8:44 PM

$PFE @walfofwallstreet “Medicus Pharma is paying the drugmaker $12 million upfront for rights to PF-08046031, which targets melanotransferrin, or CD228, a protein highly expressed in melanoma and several other solid tumors. Medicus also owes Pfizer another $15 million on Sept. 2, 2027, the first anniversary of the deal, according to a filing with the Securities and Exchange Commission. Should the ADC make it to market, Pfizer would be eligible for royalties and could also earn more than $1 billion in development, regulatory and sales milestone payments. The Big Pharma also pitched in $2 million to help Medicus get started on its new cancer prospect.’ https://www.fiercebiotech.com/biotech/pfizer-offloads-scrapped-seagen-adc-medicus-pharma-1b-deal LT

0 · Reply

walfofwallstreet Sep. 3 at 8:38 PM

$MDCX huge $1 billion dollar licensing deal finalized with Pfizer $PFE 🔥🔥 $MDCX huge upcoming 💎🫵

0 · Reply

NEWBIGTECH Sep. 3 at 8:27 PM

$PFE The Fauci diaries strongly suggest that an entire class of scientists, pundits, and officials were united in a grand scheme to delay seroprevalence for as long as possible. https://brownstone.org/articles/pfizer-and-the-cia-privately-cited-high-population-immunity-in-may-2020-unclassified-document-reveals/

0 · Reply

DipBuyInvester Sep. 3 at 8:19 PM

$MDCX will be back on fire..$PFE news!!

1 · Reply

walfofwallstreet Sep. 3 at 8:05 PM

$MDCX huge $1 billion dollar licensing deal with $PFE $MDCX huge upcoming 💎🫵

0 · Reply

walfofwallstreet Sep. 3 at 7:57 PM

$MDCX huge $1 billion dollar licensing deal with $PFE 💎🫵

0 · Reply

walfofwallstreet Sep. 3 at 7:49 PM

$MDCX 💎🚨💰👀👀👀👀🐺 Massive $1 billion licensing deal 🗞️💎🔥 $MDCX Finalized $1 billion licensing deal with Pfizer $PFE for antibody drug conjugate 💎 This is a massive deal💎 $MDCX should be up huge 🫵 huge upcoming 💎👇👇👇👇💎

1 · Reply

RookyMoves Sep. 3 at 7:08 PM

$PFE Dec 28 Leaps feel too cheap here. May add if we see one more weekly test around 27.

0 · Reply

TheWinningStock Sep. 3 at 6:12 PM

$PFE .....🤑🚀

0 · Reply

SellasgpsCurativeBAT11 Sep. 3 at 5:49 PM

$JNJ $PFE $SLS Part 2. Sellas CFO’s John Burns twin Brother Michael Burns was hired earlier in the year by Pfizer and I don’t think it’s a coincidence. 👇 ✌️🙏❤️‍🩹

0 · Reply

Market Cap	165.40B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	9.36
Forward PE	9.59
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	26,724,200
Avg Vol	40,660,152
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	75%
Beta	0.34
Analysts	Sell
Price Target	$28.60